 Nutra Pharma is providing updates on their work in utilizing their platform technology as potential countermeasures against nerve agentsPlantation, Florida--Newsfile Corp. - November 18, 2020 - Nutra Pharma Corporation OTC PINK: NPHC, a biotechnology company marketing Nyloxin, Pet Pain-Away and Equine Pain-Away in the over-the-counter OTC pain management market and which is also developing treatments for Multiple Sclerosis MS, Human Immunodeficiency Virus HIV and Pain, is providing updates today on their work in using their technologies as potential countermeasures against nerve agents like sarin gas and VX. 